Celiac Disease Foundation Venture Fund Fund I

Celiac Disease Foundation Venture Fund

cb Email

Status

ACTIVE

Global HQ

Los Angeles, United States

Countries of investment

United States

Investment stages

Pre-Seed
Seed
Series A

Industries

Biotech
Healthcare

About
The Celiac Disease Foundation Venture Fund is a strategic investment arm of the Celiac Disease Foundation, established to advance solutions for celiac disease. Its mission is to invest in promising companies to accelerate the development of new treatments and diagnostics. The fund operates on a venture philanthropy model, reinvesting all returns back into the Foundation's mission.

Min check size: $250K
Max check size: $2M
Fund size: Unlock
NPS: Unlock

Investment Thesis

The Celiac Disease Foundation Venture Fund is a venture philanthropy initiative focused on accelerating the development of novel therapeutics and diagnostics for celiac disease. The fund invests in and partners with companies creating innovative treatments and diagnostic tools. It provides unique value by leveraging the Foundation's extensive resources, including its patient recruitment network (i-Cure), deep relationships with key opinion leaders, and scientific expertise to de-risk investments and bring solutions to market faster.

Lead investor: Unlock
Co Invest: Unlock
Number of exits: Unlock
Preferred contact method: Unlock

Manager's Experience

The fund is led by Celiac Disease Foundation CEO Marilyn G. Geller and managed by a team of venture capitalists and celiac disease experts. An Investment Advisory Board, composed of leaders in biotechnology, venture capital, and patient advocacy, provides oversight. Specific details on individual managers' backgrounds, years of experience, or track records are not provided in the announcement.